Loring Wolcott & Coolidge Fiduciary Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,000
Closed -$21K 616
2022
Q3
$21K Hold
1,000
﹤0.01% 485
2022
Q2
$21K Hold
1,000
﹤0.01% 502
2022
Q1
$17K Hold
1,000
﹤0.01% 524
2021
Q4
$20K Hold
1,000
﹤0.01% 537
2021
Q3
$18K Hold
1,000
﹤0.01% 532
2021
Q2
$27K Buy
+1,000
New +$28K ﹤0.01% 517
2021
Q1
Sell
-1,000
Closed -$29K 749
2020
Q4
$29K Hold
1,000
﹤0.01% 479
2020
Q3
$24K Hold
1,000
﹤0.01% 452
2020
Q2
$18K Hold
1,000
﹤0.01% 465
2020
Q1
$8K Hold
1,000
﹤0.01% 560
2019
Q4
$13K Sell
1,000
-8
-0.8% -$97 ﹤0.01% 571
2019
Q3
$12K Sell
1,008
-152
-13% -$2.81K ﹤0.01% 555
2019
Q2
$28K Sell
1,160
-40
-3% -$1.15K ﹤0.01% 480
2019
Q1
$38K Buy
+1,200
New +$42.6K ﹤0.01% 431

Other funds holding CVET

Loring Wolcott & Coolidge Fiduciary Advisors's CVET Position: Q4 2022 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1,000 shares — an estimated $21K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CVET in Q1 2019 and held it in 14 quarters. The position peaked at $38K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 1,000 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $21K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Covetrus, Inc. Common Stock position peaked at $38K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.